Business
CBD Consumer, Science and Policy Experts Joined ONE HEMP in D.C. Briefing to Urge Congress to Meet the Market Where It is
CBD Consumer, Science and Policy Experts Joined ONE HEMP in D.C. Briefing to Urge Congress to Mee...
About this update from Charlotte's Web Holdings, Inc.
[{"type":"text","content":"\n \n \n \n CBD Consumer, Science and Policy Experts Joined ONE HEMP in D.C. Briefing to Urge Congress to Meet the Market Where It is\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Speakers from Coalition for Access Now, U.S. Pain Foundation, Balanced Veterans Network, ToxStrategies LLC and Dentons Advised Congress on CBD Regulation\n \n \n \n \n \n LOUISVILLE, Colo.\n \n \n ,\n \n \n Dec. 7, 2023\n \n \n /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. (\"Charlotte's Web\" or the \"Company\"), the industry pioneer and market leader in hemp-derived cannabidiol (CBD) wellness is pleased to announce that CBD experts and advocates joined the ONE HEMP coalition in\n \n Washington DC\n \n yesterday to meet with members of Congress and their staff on Capitol Hill.\n \n \n \n \n \n \n \n \n \n \"\n \n The message of today's briefing was clear – the supply chain bottleneck caused by lack of regulation is negatively impacting millions of CBD consumers, farmers and manufacturers. ONE HEMP has provided sensible policy solutions backed by science to open a pathway for a safe, standardized CBD industry. Today was a critical step in our next goal to secure committee hearings with Energy & Commerce and Senate HELP\n \n ,\" said\n \n \n Jared Stanley\n \n , co-founder and Chief Commercial Officer of Charlotte's Web\n \n .\n \n \n During the briefing,\n \n \n Kelly D. Fair\n \n , Strategic Advisor to ONE HEMP\n \n , Dentons U.S. Cannabis and Hemp Group Partner, and organizer of ONE HEMP's RFI\n \n submission,\n \n outlined the policy recommendations saying, \"\n \n Policy solutions must lead with science, address FDA concerns, protect states' rights, and meet the market where it is. Retailers want to sell CBD products and consumers want to access to them.\n \n \"\n \n \n The panelists featured an authoritative, in-depth discussion on the current regulatory status of CBD and the best path forward by CBD industry experts and advocates including:\n \n \n \n \n \n Jennifer Bax...